Progression free survival as a surrogate endpoint for overall survival in first-line therapy of advanced ovarian cancer : A Gynecologic Cancer InterGroup (GCIG) individual patient-level meta-analysis

BRITISH JOURNAL OF CANCER(2018)

引用 23|浏览73
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要